Inside Drug Pricing - 07/15/2019

GOP Slow-Walks Finance Deal Over Inflationary Rebates, CBO Scores

By Rachel Cohrs / July 9, 2019 at 1:28 PM
Senate Finance Committee Republicans huddled with HHS Secretary Alex Azar and White House Domestic Policy Council head Joe Grogan Tuesday (July 9) to discuss the panel’s emerging drug-pricing package, but the group did not reach an agreement. Lawmakers said a proposal from ranking Democrat Ron Wyden (OR) to cap price increases for drugs in Medicare Part D based on inflation was a sticking point and that Chair Chuck Grassley (R-IA) is waiting for Congressional Budget Office scores. Sen. Rob Portman...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.